Conceptus, Inc. (NASDAQ:CPTS)
CAPS Rating:
The Company develops, manufactures and markets the Essure(r) permanent birth control system, an innovative and proprietary medical device for women.
Get rich slowly
The Company develops, manufactures and markets the Essure(r) permanent birth control system, an innovative and proprietary medical device for women.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Insider ownership rising despite negative TTM returns.